Sign In
Buy CRSP
CRISPR Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -42.85. In total, the insiders bought 1.4M and sold 364.31K CRSP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-42.85 |
| ● Buy | 1.4M shares |
| ● Sell | 364.31K shares |
|
66% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Oct 13, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
2 114 Value: $144.4K |
||
|
Oct 13, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
2 114 Value: $144.4K |
||
|
Oct 13, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
2 114 Value: $144.4K |
||
|
Oct 13, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
2 114 Value: $144.4K |
||
|
Oct 13, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
8 334 Value: $569.1K |
||
|
Oct 13, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
8 334 Value: $569.1K |
||
|
Oct 13, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
8 334 Value: $569.1K |
||
|
Oct 13, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
8 334 Value: $569.1K |
||
|
Oct 03, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
49 500 Value: $3.35M |
||
|
Oct 03, 2025 Buy |
Patel Naimish Chief Medical Officer |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Prasad Raju Chief Financial Officer |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Prasad Raju Chief Financial Officer |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Kasinger James R. General Counsel And Secretary |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Patel Naimish Chief Medical Officer |
16 500 Value: $1.12M |
||
|
Oct 03, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
49 500 Value: $3.35M |
||
|
Sep 17, 2025 Sell |
Kulkarni Samarth Chief Executive Officer |
6 000 Value: $0 |
||
|
Sep 17, 2025 Sell |
Kulkarni Samarth Chief Executive Officer |
6 000 Value: $0 |
||
|
Aug 18, 2025 Sell |
Kulkarni Samarth Chief Executive Officer |
13 081 Value: $760.7K |
||
|
Aug 18, 2025 Sell |
Kulkarni Samarth Chief Executive Officer |
13 081 Value: $760.7K |
||
|
Aug 16, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
25 000 Value: $1.30M |
||
|
Aug 16, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
25 000 Value: $1.30M |
||
|
Aug 16, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
25 000 Value: $1.30M |
||
|
Aug 16, 2025 Buy |
Kulkarni Samarth Chief Executive Officer |
25 000 Value: $1.30M |
||
|
Apr 03, 2025 Buy |
Patel Naimish Chief Medical Officer |
1 508 Value: $49.7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
